Silicone gel breast implants at 50: the state of the science.
Aesthet Surg J., Nov;32(8):1031-4 (2012)
Safety and tolerability of high-intensity focused ultrasonography for noninvasive body sculpting: 24-week data from a randomized, sham-controlled study.
Aesthet Surg J., Sep;32(7):868-76 (2012)
Commentary on: What do patients want? Technical quality versus functional quality: a literature review for plastic surgeons.
Aesthet Surg J., Aug;32(6):760-1 (2012)
Gabapentin inhibits catecholamine release from adrenal chromaffin cells.
Anesthesiology., May;116(5):1013-24 (2012)
Patient safety at 10 years.
Aesthet Surg J., Aug;31(6):711-3 (2011)
Randomized sham-controlled trial to evaluate the safety and effectiveness of a high-intensity focused ultrasound device for noninvasive body sculpting.
Plast. Reconstr. Surg., Jul;128(1):253-62 (2011)
Evaluation of a novel high-intensity focused ultrasound device: preclinical studies in a porcine model.
Aesthet Surg J., May;31(4):429-34 (2011)
Evaluation of a novel high-intensity focused ultrasound device for ablating subcutaneous adipose tissue for noninvasive body contouring: safety studies in human volunteers.
Aesthet Surg J., May;31(4):401-10 (2011)
Noninvasive body sculpting technologies with an emphasis on high-intensity focused ultrasound.
Aesthetic Plast Surg., Oct;35(5):901-12 (2011)
Managing late periprosthetic fluid collections (seroma) in patients with breast implants: a consensus panel recommendation and review of the literature.
Plast. Reconstr. Surg., Jul;128(1):1-7 (2011)
Regulation of calcium channels and exocytosis in mouse adrenal chromaffin cells by prostaglandin EP3 receptors.
Mol. Pharmacol., Jun;79(6):987-96 (2011)
An overview of clinical trial data on a new formulation of botulinum neurotoxin type A.
Aesthet Surg J., Nov;29(6 Suppl):S31-3 (2009)
A comparison of outcomes involving highly cohesive, form-stable breast implants from two manufacturers in patients undergoing primary breast augmentation.
Aesthet Surg J., Jan;30(1):51-65 (2010)
Tissue fillers: assessing the risks.
Aesthet Surg J., 28(4):468-9 (2008 Jul-Aug)
Two-year results of a prospective, multi-site investigation of patient satisfaction and psychosocial status following cosmetic surgery.
Aesthet Surg J., 28(3):245-50 (2008 May-Jun)
Risks and opportunities for plastic surgeons in a widening cosmetic medicine market: future demand, consumer preferences, and trends in practitioners' services.
Plast. Reconstr. Surg., May;121(5):1787-92 (2008)
Breast augmentation roundtable.
Plast. Reconstr. Surg., Dec;118(7 Suppl):175S-187S (2006)
Consensus recommendations for soft-tissue augmentation with nonanimal stabilized hyaluronic acid (Restylane).
Plast. Reconstr. Surg., Mar;117(3 Suppl):3S-34S; discussion 35S-43S (2006)
Foreword: Introduction to Restylane SubQ, a novel non-animal stabilized hyaluronic acid tissue filler (NASHA).
Aesthet Surg J., 26(1S):S3 (2006 Jan-Feb)
Reconstruction in women with bilateral prophylactic mastectomy: a descriptive study.
Plast. Reconstr. Surg., Oct;116(5):1557-8 (2005)
A prospective, multi-site investigation of patient satisfaction and psychosocial status following cosmetic surgery.
Aesthet Surg J., 25(3):263-9 (2005 May-Jun)
Teenage breast augmentation: validating outcome data and statistics in plastic surgery.
Plast. Reconstr. Surg., Mar;115(3):943-4 (2005)
Decision and management algorithms to address patient and food and drug administration concerns regarding breast augmentation and implants.
Plast. Reconstr. Surg., Oct;114(5):1252-7 (2004)
Patient safety data: how it can improve our performance.
Aesthet Surg J., 24(4):346-8 (2004 Jul-Aug)
David Weaver Robinson, M.D., 1914 to 2003.
Plast. Reconstr. Surg., May;113(6):1863-4 (2004)
Medical errors and aesthetic plastic surgery.
Aesthet Surg J., Mar;23(2):108-9 (2003)
Non-narcotic acute pain relief after ambulatory aesthetic surgery.
Aesthet Surg J., Sep;22(5):493-4 (2002)
Lost in the rush hour on the information superhighway.
Plast. Reconstr. Surg., Sep;98(4):721-2 (1996)